Lipoprotein-associated phospholipase A2 (PLA2G7) silencing was recently reported that could as a novel therapy involving in anti-proliferative, anti-migratory and pro-apoptotic in tumor cells. The gene discussed is PLA2G7; the disease is neoplasm.